77 related articles for article (PubMed ID: 3065737)
1. Immunoglobulin replacement in chronic lymphocytic leukaemia.
Bunch C
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):419-22. PubMed ID: 3065737
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin in chronic lymphocytic leukaemia.
Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin replacement therapy by self-infusion at home.
Chapel H; Brennan V; Delson E
Clin Exp Immunol; 1988 Jul; 73(1):160-2. PubMed ID: 3168330
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
Keegan A; Dennington PM; Dhondy N; Mulligan SP
Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
[TBL] [Abstract][Full Text] [Related]
6. Clinical usage of intravenous immunoglobulins in Auckland.
Lee YC; Woodfield DG; Douglas R
N Z Med J; 1998 Feb; 111(1060):48-50. PubMed ID: 9539915
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial.
; Gale RP; Chapel HM; Bunch C; Rai KR; Foon K; Courter SG; Tait D
N Engl J Med; 1988 Oct; 319(14):902-7. PubMed ID: 2901668
[TBL] [Abstract][Full Text] [Related]
8. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
9. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
Boughton BJ; Jackson N; Lim S; Smith N
Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
[TBL] [Abstract][Full Text] [Related]
12. The immunodeficiency of chronic lymphocytic leukaemia.
Hamblin AD; Hamblin TJ
Br Med Bull; 2008; 87():49-62. PubMed ID: 18755702
[TBL] [Abstract][Full Text] [Related]
13. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia.
Aghamohammadi A; Moin M; Farhoudi A; Rezaei N; Pourpak Z; Movahedi M; Gharagozlou M; Nabavi M; Shahrokhi A
FEMS Immunol Med Microbiol; 2004 Mar; 40(2):113-8. PubMed ID: 14987729
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
16. [Personal experience with replacement therapy with intravenous gamma globulin].
Litzman J; Lokaj J; Stikarovská D; Mayer J; Thon V; Eibl MM
Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
Besa EC
Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
[No Abstract] [Full Text] [Related]
18. Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.
Griffiths H; Brennan V; Lea J; Bunch C; Lee M; Chapel H
Blood; 1989 Feb; 73(2):366-8. PubMed ID: 2492832
[TBL] [Abstract][Full Text] [Related]
19. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
[TBL] [Abstract][Full Text] [Related]
20. [Immunoglobulin substitution in malignant lymphoma].
Wehmeier A
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():73-6; discussion 77. PubMed ID: 8499755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
